Considerations of antibiotic therapy duration in community- and hospital-acquired bacterial infections

J Antimicrob Chemother. 2012 Nov;67(11):2570-5. doi: 10.1093/jac/dks277. Epub 2012 Jul 24.

Abstract

Despite the large number of suggestions available in the literature, the optimal duration of antibiotic treatment remains an individual decision mainly based on clinical criteria. Shorter but equally effective regimens would reduce the side effect rates, including both antibiotic resistance and drug expenses. Although several prospective, randomized trials and meta-analyses with the aim of comparing a standard duration with a shorter one for most bacterial infections have been published, to date most current recommendations carry little weight, as they are based on expert opinions or practical experience. This review will briefly touch upon the clinical evidence of short-course versus long-course antibiotic therapy for the most common community- and hospital-acquired bacterial infections.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Bacterial Infections / drug therapy*
  • Community-Acquired Infections / drug therapy*
  • Cross Infection / drug therapy*
  • Drug Resistance, Bacterial
  • Humans
  • Time Factors

Substances

  • Anti-Bacterial Agents